Milestone for cannabinoid MS study
Monday, July 21, 2008 - 11:14
in Health & Medicine
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study.
Read the whole article on Physorg
More from Physorg
Related
- Milestone for cannabinoid MS studyMon, 21 Jul 2008, 12:14:52 EDT
- Multiple sclerosis progression can be predicted with MRIWed, 5 Nov 2008, 16:43:21 EST
- Tracking down the causes of multiple sclerosisWed, 10 Jun 2009, 13:25:13 EDT
- Glutamate identified as predictor of disease progression in multiple sclerosisThu, 30 Apr 2009, 2:11:24 EDT
- Cognitive testing, gender and brain lesions may predict MS disease progression riskWed, 29 Jul 2009, 16:54:22 EDT